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2.

PSYCHOPHYSIOLOGICAL TENSION IN MENSTRUATION
INTRODUCTION
This problem of menstruation is seemingly well
known, but in reviewing the literature one is impressed
with the scarcity of good information.

At the present time,

the greatest amount of information is descriptive in nature
and usually goes under the name of lithe premenstrual syndrome."
The explanations for this syndrome, whether psychological
or physiological, are numerous, but exploration of the
problem has been of minor significance and incomplete.

Infor-

mation about attempts at treatment is scanty and conflicting.
One major problem is the small scale of the previous investigations and the lack of coordinated studies.

An attempt

will be made in this paper to summarize the findings of
previous investigations as reported in the literature in
order that the overall complexion of the problem can be
assessed.
DEFINITION AND

OCCU~NGE

The term "premenstrual syndrome fl was originally
used by Frank in 1931, but in 1963 Coppen proposed the use
of the term "cyclic syndrome."

5

His reasons were:

(1)

It dispenses with restriction in time imposed by the word
premenstrual; (2)

It draws attention to the fact that it

is more likely to be related to pituitary activity, and
thus complex hypothalamic and endocrine multiglandular
interaction than merely to a basically pelvic disturbance;

3.

(3)

It presents a concept of psychology rather than pathology

with the inference that many features may occur which do not
demand treatment.

While no recent literature has disputed

the term used by Coppen, the term premenstrual syndrome
still prevails, probably by tradition.
The premenstrual syndrome is not just a given set
of symptoms and signs which must be found in a person to
classify them as having the premenstrual syndrome.

It

contains many signs and symptoms, only a few of which
need be combined to qualify for the syndrome.
a rare academic syndrome, either.

It is not

Estimates vary that from

25 to 100 percent of women have increased psychic and somatic
disturbances during ovulation, premenstrually or menstrually.
One of the most commonly quoted figures for women
having premenstrual tension syndrome is 70 per cent.

This

figure was obtained by Eichner, using a group of student
3
nurses as controls in a questionnaire study.
He found
that 70 percent of the nurses had one or more of the common
4
symptoms of premenstrual tension. Morton using a group
of female prisoners found that 80 percent of 249 had premenstrual tension.

As stated before, however, the figure

varies from 25 to 100 percent, depending on which study is
quoted and what definition of premenstrual sydrome is being
used in that study.
In their study of the premenstrual syndrome,
Coppen and Kessel used a questionnaire to obtain information
from 150 nulliparas.

Their data revealed that 76 percent

4.
had regular menses.

5

The mean duration was 4.8 days and

54 percent contained clots.

There was no pain reported

in 17 percent, 47 percent reported pain in the premenstrum,
and 66 percent had pain with menstruation.

In the group

with premenstrual tension, premenstrual pain was found in
12 percent, menstrual pain in 25 percent.

Other common

complaints menstrually or premenstrually are given in
Table I.

tension.

Not all findings are subjective during premenstrual
8
Goldfarb, in a pamphlet on premenstrual tension,

lists the following objective findings:

glycemia, neutro-

philia, lymphocytopenia, suppression of capillary resistance,
digital sweating and increased sensitivity of the respiratory
center.

What the above shows is what Coppen, Dalton and

others have come to agree on, that any combination of the
above occurring cyclincally constitute what can be called
"the Premenstrual Syndrome."

See Table II.

PSYCHOLOGICAL ASPECTS
To illustrate some of the psychological overtones
associated with the menstrual cycle and menstruation in
particular, Dalton divided a 28 day month into seven
four-day periods.

She then measured the time of admission

of 276 female acute psychiatric patients.

The expected

probability was 14 percent during any four-day period.
Dalton found 28 percent admitted during menstruation and
17 percent in the four days prior to menstruation.

Of 36

attempted suicides, 39 percent were during menstruation and
14 percent were premenstrually.

Depression accounted for

5.

TABLE I
COMPLAINTS:

MENSTRUALLY AND PREMENSTRUALLY

1)

Cyclical acneform eruption

70%

2)

Irritability

69%

3)

Depression

63%

4)

Swelling in some part of body

63%

5)

Headache

32%

6)

Constipation

20%

7)

Dizziness

16%

8)

Diarrhea

13%

9)

Insomnia

5%

Spots before eyes

2%

10)

The above list of symptoms has been confirmed
numerous times although there may be variations
in the frequency of occurrence of different
symptoms. Greenblatt lists irritability, depression,
insomnia, headaches, breast turgidity, premenstrual 6
edema, and nausea as the seven most common symptoms.

6.

A study by Hood and Bond yielded the following
7
figures for premenstrual symptoms.

TABLE II
SYMPTOMS OF PREMENSTRUAL SYNDROME
No. Of
Patients

Percent

Irritability

25

100

Headache

23

92

Bloating

22

88

Breast engorgement

21

84

Nausea

15

60

Abdominal cramping

14

56

Edema

11

44

9

36

SlmEtom

Acne

7.

185 patients, and, of this group, 33 percent were menstruating and 14 percent were premenstrual at the time of
admission.

Of 114 with an admitting diagnosis of schizo-

phrenia, 26 percent were menstruating and 21 percent were
9, 10
premenstrual.
In another study, Dalton found that of 156 female
prisoners, 28 percent committed the crime while menstruating
and that 22 percent of the crimes were premenstrual.

A

study using autopsy material revealed that of 22 Hindu
women committing suicide by fire, 19 of the women were
12
menstruating.
The amount of data could probably be endless in proving that there is often psychological tension
associated with menstruation and in the premenstrual period,
but the question is, why?

The reasons given for the premen-

strual syndrome range from strictly psychological to physiological, which most commonly involves hormonal studies.
The most commonly accepted psychological view
"indicates that the perception of her menstrual flow intensifies a woman's pre-existing conscious and unconscious conflicts about pregnancy, having a child, castration fears,
uncleanliness, lack of control of bodily functions, aggression,
penis envy and masturbation.

In the presence of a vulnerable

ego structure; neurotiC, psychotic or characterological
reactions may occur.

In most women the compensation for the

deprivations associated with femaleness is the process of
pregnancy and the bearing of a child.

Hence, the common

8.

psychoanalytic observation that a menstrual period is
experienced as a "lost child."

13

Some people, while realizing the above explanation
and accepting it, have added to it more of the environmental
aspects of life.

Mary Chadwick, who wrote the book, The

Psychological Effects of Menstruation, devotes one chapter
to the common tribal taboos associated with menstruation.
The book points up some interesting aspects which have not
been fully studied, but which can be speculated about.

An

example was the fact that people in Brunswick thought IIthat
if a menstruous woman assists at the killing of a pig the
pork will putrefy."

14

What effect did this have, and what

effects do similar taboos of the past or present have on
women today?
Some investigators have continued a step further
and correlated the psychology with the physiology.

One

such study indicates that estrogen correlates to heterosexual tendency, masculine identification and infantile
tendencies.

Progesterone was correlated to homosexual tendency,

narcissism, mother conflict, pregnancy and nursing tendencies.
Low hormone levels were matched with dependence, depression
and withdrawal, anal and genital elimination tendency and
a destructive tendency.

15

The most commonly studied psychological factor
relates to neuroticism.

Rees found that the premenstrual

syndrome was associated more frequently with neurotic
indiViduals and that neuroticism is also higher in women

9.

with irregular periods.

Rees made the following concluding

statement, "It appears women who complain of premenstrual
irritability are irritable at other times as well and it
seems therefore, that menstrual symptoms are exacerbations
of personality traits which in turn are related to
neuroticism."

16

To illustrate the above point, a study done by
Irwin Perr

17

serves appropriately.

(Table III).

The major conclusion to be drawn from the preceding study was admirably stated by Suaiez-Murias when he
18
"The psychologic aspect of premenstrual tension
wrote,
seems related largely to the manner in which the patient
accepts psychically the menstrual function and also to the
manner in which the patient unconsciously utilizes the
menstrual function to express distress about pressing
environmental situations of life, difficult interpersonal
relationships, or about her own attitude concerning being
a woman, or even about the fact of existence."

In other

words, personality type and environmental setting are the
real factors in the psychologic manifestations of premenstrual
20

tension.

Israel,

one of the foremost writers on the

premenstrual syndrome, stated this exact thought as follows:
"Irrespective of the exacting mechanisms it cannot be
denied; because of the nature of the symptoms, that emotional
disturbances and psychogenic traumata not only aggrevate
the symptoms, but evoke additional ones."

10.

TABLE III
INCIDENCE OF PREMENSTRUAL TENSION
IN NORMALS AND NEUROTICS
Degree of Tension

Neurotics (84)

Normals (61)

None

78.7%

38%

Moderate

16.4%

30%

5.0%

32%

Severe

THE INCIDENCE OF PREMENSTRUAL TENSION RELATED TO
DEGREE OF NEUROTIC CONSTITUTION
Degree of Neurotic
Constitution

Degree of Premenstrual Tension
Nil or Mild

Moderate

Severe

Nil

16%

17%

7%

Mild

56%

36%

8%

Severe

15%

48%

37%

11.

PHYSIOLOGICAL ASPECTS

?

"That pathologic emotional findings are biochemically influenced is widely accepted.

Speculations as

to etiology are reviewed in Southam's article and include
sodium and water retention, excess of aldosterone, allergy
to progesterone and its metabolities, a menstrual toxin,
20

excessive antidiuretic substance and hypoglycemia.
An increase in mineral corticoids and glucocorticoids in
relation to ovarian steroids, a high estrogen-progesterone
ratio and effect of adrenocortical hormones in general
2

have also been suggested as etiologic factors.
The most widely accepted physiological explanation
for tension during the menstrual cycle is sodium retention
and its accompanying water retension.

One study showed

that of 42 normally menstruating women, 30 percent gained
three or more pounds premenstrually.

It is felt that the

water and sodium retention secondarily may cause lowering
of nerve activation thresholds and thus more nervous system
irritability.

The lowered threshold is manifested clinically

by a weakening of ego controls according to the characteristics
21

of the predisposing personality structures.
The increased fluid retention or increased steroids
at various times during the menstrual cycle have also been
thought to cause relative hypoglycemia and thus psychiatric
symptoms.

Common symptoms associated with hypoglycemia are

depression, insomnia, anxiety, irritability, fatigue,
swea~ing,

headache and dizziness.

The hypoglycemia may

12.

be due to decreased glucose tolerance from increased
glucocorticoids or other steroids, possibly estrogen,
22

during the premenstrual period.
Thorn

23

in 1938, did the classical work in the

area of menstrual edema.

He did a study in which he showed

that out of 50 normal women, 24 (48 percent) gained one
kilogram or more premenstrually and that 38 (76 percent)
gained one kilogram or more about the time of ovulation.
Thorn postulated this was due to increased hormones, probably
estrogen.

Using dogs and injecting sex hormones, Thorn was

then able to assay the salt retaining property of these
hormones.

He found that the following had salt retaining

property:

(They are listed in decreasing order of potency.)

1)

Estradiol, 2) Progesterone, 3) Estrogen, 4) Pregnanediol,

5) Testosterone.

It is very probable that estradiol accounts

for much of the premenstrual fluid retention.
Morton experimentally verified this by studying
24
29 patients with premenstrual syndrome.
In these patients,
he followed basal temperatures, endometrial biopsy, vaginal
smears and urinary hormones, during the premenstrual phase
in particular.

Morton was unable to demonstrate an abrupt

rise in temperature at midcycle, found proliferative or mixed
endometrium, cornified vaginal cells and subnormal prenanediol
excretion in 10 of 14 patients, indicating that estrogenic
activity was much greater than progestational activity.
Estradiol peaks at ovulation and in the premenstrual
phase and is often given as the cause for water retention.

25

~

13.

Morton suggests that it is actually the estradiol/progesterone
26
ratio that causes the water retention.
In fact, the
premenstrual syndrome has been induced in castrates and menopausal patients by large doses of estrogen.
The plausibility of the above theory is nicely
explained in Drill's Textbook of Pharmacology 1965, and
it also accounts for the implication that aldosterone is
involved in the Premenstrual Syndrome.

Drill states that,

"Estrogens can promote sodium retention, with associated
fluid retention and edema.

This is more prone to occur

only when high doses of estrogen are used.

However, the

effects of estrogen upon fluid retention are less severe
than those seen after testosterone or glucocorticoid therapy.
In all probability, it may be the decrease in progesterone
level that is responsible for the fluid retention.

Since

progesterone displays anti-aldosterone activity, the lowered
progesterone secretion level permits aldosterone, which
increases at this time to induce fluid retention."

Gluco-

corticoids have also been implicated because they have many
of the water retention properties of mineralcorticoids.

27

That aldosterone is indeed elevated in the
luteal phase of the menstrual cycle has been demonstrated by
Strausfeld.

He demonstrated that aldosterone secretory rates

range between

lOO~g

during the follicular phase in females,
r'

while during the luteal phase the range is between
and

350~g.

23cr~g

The rates in the luteal phase were all outside

the normal range for a male.

In one woman with premenstrual

tension, the luteal secretory rate was five times that

14.

28
found in the follicular phase.

An additional cog in the

wheel is the fact that emotional stress can activate the
adrenal cortex in man, thus increasing steroid levels in
the peripheral blood.

29

The question arises, however,

as to how much stress menstruation causes?
One last hormone should be mentioned as a possible
cause of fluid retention, i.e. antidiuretic hormone (ADH).
Although ADH has not commonly been discussed as a cause
for premenstrual tension, Pendergrass

30

did an interesting

experiment involving irradiation of the posterior pituitary
in humans.

He felt that ADH may cause premenstrual tension

and therefore he irradiated the pituitary glands of women
with fluid retention premenstrually.

Initial success was

noted in approximately 50 percent of his cases.

One-third

of the cases had no ADH substance in the urine following
irradiation.

A point not fully explained in this study is

the method or feasibility of destroying only the ADH
producing center.

What else may have been involved?

Of final significance in the etiology of
premenstrual tension is the theory of Macht and others
who feel that the pathology is caused by a toxin, "the
menotoxin!'

31

Macht felt the "menotoxin" was toxic to

both plant and animals and was found circulating in the
blood at the time of the menses.

He proposed that the

"menotoxin" was closely related pharmacologically to the
phenanthrene derivatives, cholesterol and oxycholesterol,
although it was a separate entity.

The possibility that

the "menotoxin" was a breakdown product of the steroid
hormones was included as a possible origin.

15.

TREATIVIENT
Treatment of the premenstrual syndrome has been
aimed mainly at the problem of fluid retention.

Low salt

diets, diuretics and lithium have been used, but they do not
seem to be of significant value.

Progesterone may be one

of the most useful preparations in the premenstrual syndrome
because of its action as an antagonist of aldosterone.
Other ideas which have been tried but which showed little
promise are androgen, vitamins, and oophorectomy.

25

The best studied of the theraputic regimens for
the premenstrual syndrome seems to be the so called'multiR

demsional" approach.

This is a preparation (Pre-Mens )

composed mainly of ammonium chloride as a diuretic, homatropine and a number of vitamins, Vitamin B complex being
the main vitamin.

Vitamin B. complex deficiency supposedly

affects the ability of the liver to destroy estorgens which
are probably an important causative factor in premenstrual
tension.

Homatropine acts as an antispasmodic.

32

Morton's study of 249 female prisoners with
premenstrual tension indicated that:
1) 15 percent of inmates reported improvement
when given placebos.
2) 30 percent of inmates reported improvements
with placebos and high protein diet.
R

3) 61 percent of inmates given Pre-Mens
improved.

only

4) 79 p~rcent of inmates improved when given
Pre-Mens plus high protein diet.

16.
R

Thus, from this study, Pre-Mens

seem to be quite effective.

Eichner and Waltner demonstrated 50 percent of 86 women

R 32
had a complete relief of congestive symptoms with Pre-Mens •
Many had partial improvement.
Although ammonium chloride is thought to be the
R

main functional chemical in Pre-Mens , Eichner has shown that
the "multidimensional" tablet is superior to ammonium chloride
33
R
alone.
Pre-Mens has also produced improvement of the
acne associated with the Premenstrual Tension Syndrome.

In

one study, 42 of 50 patients improved; 33 improved markedly.
R

Pre-Mens
alone.

34

worked three times better than ammonium chloride

Other diuretic preparations have also been used
to treat the

~remenstural

syndrome, although none have been

so well studied as ammonium chloride.

Of the other diutetics,

the thiazides have been bes't studied, but much more information is needed.
by Bushnell.

35

One of the few studies available was done
In this study the author gave 36 patients

with symptoms of premenstrual tension 5 to 7.5 mg. of
methyclothiazide each day during the ten day period prior
to the onset of menses.

After continuing treatment over

a one to five year period, the author observed that symptomatic
response was excellent in 15 patients; good in 20; and fair
in one.

Similar results may be found in the works of

Winshel and Shabanah.

36, 37

Shabanah recorded weight losses

of from two to ten pounds in 72 hours.

Taking these reports

17.

into account, the thiazide diuretics may be as good as
R

Pre-Mens
b~

and better than annomium chloride.

It should

noted that while the diuretics often totally relieved

symptoms of premenstrual tension, they were best at
relieving the symptom of pelvic congestion.
The second major group of agents used to treat
the premenstrual syndrome are the hormones.

Many have

felt that they are the answer, since very probably estrogen
is a causative factor in premenstrual tension.

It now

becomes apparent that they are only partially the answer.
Even the proposed cause of the syndrome, estrogen, has been
tried as a method of treatment, and with reported success.
In a number of cases they seem to be of help.

Greenblatt

feels that simple estrogens, like estriol, help but complex
6

estrogens such as estradiol may aggrevate the condition.
No well planned experimeni1f: have been carried out to investigate this problem.
Progesterone has been studied much more than
estrogen as a method of treatment for the premenstrual syndrome.
Altl!ough it has not been proven conclusively, that
women with premenstrual tension are relatively deficient
in progesterone, this is a generally accepted theory.

Hence,

people have used progesterone as treatment.
R

Enovid

(norethynodrel with added ethinyl estradiol)

has been one of the best studied progestational agents.
R

Heller and Hood have both confirmed that Enovid

relieves

18.

the premenstrual syndrome.

38, 7

Hood studied 25 patients
R
with premenstrual tension, each receiving Enovid as
R
treatment. The usual symptoms were noted and Enovid
was used in the prescribed method.

Of the 5 patients,

21 obtained at least partial relief.
high, however.

Side effects were

Nausea with the first treatment cycle was

experienced by 22 patients, nausea in subsequent cycles
by 8, breast engorgment in 22, and delayed menses in 11.
R
Although Enovid is of benefit in a high percentage of cases,
Hood made the following comment in summarizing his study,
"There appears to be no advantage over other therapeutic
agents for the control of premenstrual tension."

In fact

the Food and Drug Administration has found this to be quite
R
true and does not recognize Enovid as treatment for
premenstrual tension. (Refer to letter from Searle & Co.
at the end of paper).
Testosterone is the last of the hormones to
be tried.

Once again adequate studies have not been done,

and one must follow impressions only.

Enough has probably

been said if one mentions that Greenblatt and Freed have
both had good results with testosterone, although they
found it may aggrevate water retention.

39, 40

Many other agents and methods for treating premenstrual tension have been recommended over the years.

In

most cases these agents have been adopted empirically for
use in premenstrual tension after studies have shown their
value in relieving the same symptom when not associated with

19.

the premenstrual syndrome.

Examples of this are the minor

analgesics such as aspirin, the tranquilizers such as
reserpine or the phenothiazines.

All have been used in

treating premenstrual tension and are often successful
in relieving a specific symptom.

Other drugs have been

mentioned for treating the premenstrual syndrome such as
Vitamin B to increase liver destruction of estrogen (studied
R

by Biskinds).

Bellergal

an autotomic depressant and anti-

spasmotic drug, which has been studied by Craig has also
42
been used.
The best overall summary of the results of treatment using many of the drugs discussed in this paper can
be found in two charts from an article on the premenstrual
syndrome by Edward Eichner.

33

A copy of the charts from

this paper can be found on the following page.

SUMMARY
The premenstrual syndrome, while being a common
problem, is also a bothersome one.

The entity is well

described and reduplicated in the literature, but as with
many human functions, it is complex.

Its causative factors

are probably an interaction of psychic aspects and hormonalphysiologic functions.

Because of the complexity of the

syndrome no one cause will probably be found and no one
treatment will be the answer.
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CHART 1
DIURETIC TREAT'IEr\T FOR

PRE:\IE~STRUAL TE~SIO~
----

R,

No.
Satisfactory
Patients
ReSlllts

Dosage

Acetazolamide (DiamoxE) ______________ .______ 0.125 - 1.0 Gm. Daily to Relief,
Start with Symptoms
Ammonium Chloride, Plain-coated __________ 4.0 Grn. Q.I.D. for -I Days,
Start with Symptoms __
Hg - Theophylline Cmpd:
____ 1 - 2 ce. Intragluteal, Once at Onset
(Cun1t'rtilinE Inject.) ___ _
_ _______ 2 Tabs. Q. A\[ to Relief, Start \\'ith
(CumertilinE Oral Tah.)
Symptoms
_____________ ' ________ _
_______ . __ 1 Tab. Q.I.D.:3 D'lYS (less is inadequate)
Aminometramide (\lictineE)
_1 Tab. Q.I.D. 2 Days, Then 1 Tab. B.I.D.
Aminoisometradine (RolictonE)
15th Day Cycle to Onset of Flow _
__ 62.5 - 2.50 \lg. Dail~- :3 Days Starting with
Ethoxzolamide (Carclrast:1':)
Onset of Symptoms _. ________________________ _
62 ..') - 2')0 \[g. Q.2.D. Starting IBth D.
I Tall. ll.I.D. I.')th 1),1' til Onset of Flow,
Hydrodllorothi.tzide (I I~ dr()(liurilft)

62

:3:3.9

12.9

38

28.9

IS.1

15

40.0

6 .•

30
.')

26.6
20.0

10.0
60.0

:!:3

:39.1

8 .•

.')

40.0

9

'J'),-)

40.0
22.2

7

'Ji .:..

--

2B.6

19-1

:):)})

I·U

or Dllratioll S\llli,tollls

To 1.\1.

OF

D"

•

III I I < "

III
Effects

:'I .....

;")

)

CHART 2
TREATI1E~T

OF PRE:\lEr\STlWAL TE~SIO~
-.-- ---_._--.
- ---------_._-- -- _.- _..
-'--- '----,.- _. - --- ---_.. -.-----------.--No.
Satisf(Jctory
III
Dosllge
Patients
Results
Effects
-

-

DIET: '- Hi-Protein, Lo Sodilull

~--

-

~----

. (200 \Ig. ~a Daily) Starting l.5th Day
of Cycle _____________ . ___________ ._. ___ .___ 347

1.5.3

194

3:3 ..5

14.4

242
Scheduil' Constant for All Types
2 Tah. "Ll.D. Starting with SYlllptoms.
2H
Discontinul' with Helief or in .5 Days. 121
Restart 50S c Symptoms.
45

8·U
6-1.:3
81.0
8.8

.5.0
42.8
6.6
11.1

61.5

24.6

.57.1

42.8

22.2
42.9
50.0
20.0
50.0

22.2
28.6
40.0
40.0
.", .,
'.)'.).'),

ALL DIURETICS
POLYl'JI:\I\\!:\CAL \IEDICATIO~:
PrclIIl'llslc Plain
Premcns \\'ith AlllphetalllinC®
Premens with Reserpine
Placebo Control
Diamox Compound*
"A", "B", '·C" _____________________________

--

-."

O.O'7c

1 - 2 Caps. D'lily Starting 7 - 10 Days

Before Expected Onset of FIO\\' __ _ 26
Ethisterone Compound* __________________ l - 2 Tabs. Daily Starting 7 - 10 D'IYS
Beforc Expl'cted Onset of ~'Io\\' __
14
SY~TIIETIC STEHOIDS
Ethisterone Compuund
SeC' I'olyplwrlllalotl \["dicatioll-Ill Effects Primarily
JIea\'y or Prolollg(·d Blceding
2.30 - :37.5 \[g. 1.\1. l:3tll - 18th D'l)
Delalutin'l;
Cyde
__ ______________
9
1 Tab. 5th thru 2.5th D'l) Cycle, or _____ _ 7
1 - 2 Tahs. Daily I.3th - 2.Sth Da) Cycle 10
.')
Braxorone _ ___ __________________________ .. 2 . 6 Tahs. Daih- .5th thm 2.5th D'lL
2 - 6 Tabs. Dail;- l.5t1l - 2.5th Day C;'cle
6
*Series incomplete

Prom Eichner, E., I'remen;c;trual 'rension Syndro;:''1e and :Fri.::c:ary
".1
'['
'.' d
T
Dysmenorrhea, 1!.,.
56:1-8 1960.
'l.r6· ~.~.,

\
\
I

\

,

\
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Research in the Service of Medicine

& CO.

G. D.

P. O. BOX 5110, CHICAGO, IlliNOIS 60680. Telephone (312)-463-21i1

January 2, 1969

Mr. Richard D. Schmidt
608 So. 38 St., Apt. 5
Omaha, Nebraska 68105
Dear Mr. Schmidt:
Many thanks for your letter of December 12 in which you
request information concerning the use of Enovid for
treatment of patients with premenstrual tension.
Enclosed are several published reports in which you will
be interested.
Sometime ago, however, the Food and
Drug Administration withdrew approval for recommending
this cli~ical application of Enovid and our only current
claims for this preparation are those described in the
enclosed information leaflets for Enovid 10 mg, Enovid
5 mg and Enovid-E.
I

hope you will find this material to be of assistance.
very sincerely,
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J. William Crosson, M. D.
Assistant Medical Director
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